Open AccessRisk of Fracture after Androgen Deprivation for Prostate Cancer
Author(s) -
Vahakn B. Shahinian,
YongFang Kuo,
Jean L. Freeman,
James S. Goodwin
Publication year - 2005
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa041943
Subject(s) - androgen deprivation therapy , medicine , prostate cancer , androgen , bone mineral , oncology , prostate , endocrinology , cancer , hormone , osteoporosis
The use of androgen-deprivation therapy for prostate cancer has increased substantially over the past 15 years. This treatment is associated with a loss of bone-mineral density, but the risk of fracture after androgen-deprivation therapy has not been well studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom